Published: 2022-10-21

Review Article

Sodium-glucose Co-transporter 2 Inhibitors: A Novel Molecule for Health Care Practitioners in Diabetology, Cardiology and Nephrology

AG Unnikrishnan, Kamlesh Khunti, Tiny Nair, Aravinda Jagadeesh, Vedavati Purandare

20-31

PDF

Will Oral Semaglutide be a Game-Changer in the Management of Type 2 Diabetes in Indian Context?

Arjun Baidya, Saurabh Mishra, Ashok Venkatanarasu
PDF

Editorial

Diabetes Management: Dynamism Ahead

Sanjay Kalra

5

PDF

Original Article

Usage of Low-dose Glimepiride (0.5 mg) and Metformin Combination in the Management of Type 2 Diabetes Continuum in Indian Setting

Pankaj Jain, Rajeev Kasliwal, Shailendra Kumar Singh, Ajay Shah, Vrin Kumar Bhardwaj, Jay Chordia, Ankur Sinha, Mahesh Abhyankar, Ashish Prasad, Mayuri Talathi

8-19

PDF

Lighter Reading

Lighter Side of Medicine

42

PDF

Guest Editorial

Insulin is Essential: The National List of Essential Medicines, India, 2022

Sanjay Kalra, Suneet Kumar Verma, Rakesh Sahay

6-7

PDF

Clinical Perspectives

Imeglimin: Finding a Place in Modern Diabetes Pharmacotherapeutics

Sanjay Kalra, Saptarshi Bhattacharya, Shehla Shaikh

38-40

PDF